Pfizer

CDC recommends Pfizer COVID booster for kids as young as 12
NPR
Wed, 01/5/22 - 10:53 pm
Pfizer
BioNTech
adolescents
CDC
vaccines
boosters
COVID-19 pneumonia
4th Pfizer shot sparks fivefold antibody boost, Israeli study finds
Beckers Hospital Review
Wed, 01/5/22 - 10:46 pm
Pfizer
BioNTech
COVID-19
vaccines
boosters
Israel
Pfizer, BioNTech to develop shingles shot, after COVID-19 vaccine success
Reuters
Wed, 01/5/22 - 10:47 am
Pfizer
BioNTech
vaccines
MRNA
shingles
Pfizer carries pandemic momentum into 2022, scoring another huge Paxlovid deal with the US
Fierce Pharma
Tue, 01/4/22 - 10:54 pm
Pfizer
COVID-19
Paxlovid
Joe Biden
Pfizer, GSK and Teva lead 2022's round of January drug price hikes: GoodRx
Fierce Pharma
Tue, 01/4/22 - 10:43 pm
Pfizer
GSK
Teva Pharmaceutical
drug pricing
FDA authorizes the first at-home pills from Pfizer to treat Covid-19
Endpoints
Mon, 01/3/22 - 10:51 pm
Pfizer
FDA
nirmatrelvir
ritonavir
FDA authorizes first Covid-19 booster shot for teens aged 12 to 15
Stat
Mon, 01/3/22 - 10:50 am
FDA
Pfizer
BioNTech
vaccines
boosters
COVID-19
Pfizer Snagged Another Approval for This Immunology Drug
Motley Fool
Mon, 01/3/22 - 10:48 am
Pfizer
ankylosing spondylitis
Xeljanz
10 clinical trials to watch in the first half of 2022
BioPharma Dive
Mon, 01/3/22 - 10:46 am
clinical trials
Pfizer
Arena Pharmaceuticals
etrasimod
Sanofi
GSK
vaccines
COVID-19
Roche
gantenerumab
AbbVie
Gilead Sciences
Trodelvy
Karuna Therapeutics
KarXT
Intercept Pharma
obeticholic acid
Allogene
ALLO-501a
Is Pfizer's Acquisition of Arena a Good Move for Investors?
Motley Fool
Mon, 01/3/22 - 10:33 am
Pfizer
Arena Pharmaceuticals
M&A
Bristol Myers Squibb, Amgen and Pfizer approach steepest patent cliffs among large drugmakers
Fierce Pharma
Fri, 12/31/21 - 11:10 am
patents
patent cliffs
Bristol Myers Squibb
Amgen
Pfizer
Revlimid
Eliquis
Enbrel
Otezla
Ibrance
F.D.A. Plans to Allow 12- to 15-Year-Olds to Receive Pfizer Boosters
NY Times, NY
Thu, 12/30/21 - 07:57 pm
Pfizer
COVID-19
pediatric
vaccines
boosters
adolescents
Pfizer to deliver 2.5 million additional doses of Covid-19 pill to UK
Pharmaceutical Business Review
Sun, 12/26/21 - 11:12 pm
Pfizer
Paxlovid
COVID-19
UK
2022 forecast: Will biopharma's offices ever go back to 'normal'? Sanofi, Novartis and more chime in
Fierce Pharma
Wed, 12/22/21 - 11:37 pm
COVID-19
pandemic
remote work
Sanofi
Biogen
Pfizer
Novartis
COVID-19 pill from Pfizer authorized by FDA in major pandemic milestone
BioPharma Dive
Wed, 12/22/21 - 02:29 pm
Pfizer
Paxlovid
antivirals
COVID-19
FDA
Pfizer reports patient death in early-stage Duchenne gene therapy trial, halts enrollment
Fierce Biotech
Tue, 12/21/21 - 10:28 am
Pfizer
clinical trials
Duchenne Muscular Dystrophy
gene therapy
patient deaths
PF-06939926
Go or no go? Roche’s fresh start for a new year
EP Vantage
Mon, 12/20/21 - 10:59 am
FDA
Roche
Novartis
Pfizer
AstraZeneca
Cibinqo
Lynparza
Tezspire
Vyvgart
faricimab
What to Make of the FDA's Latest Warning to AbbVie and Pfizer
Motley Fool
Sat, 12/18/21 - 10:56 pm
FDA
AbbVie
Pfizer
Rinvoq
Xeljanz
JAK inhibitors
This New Study Could Give Moderna a Big Advantage in 2022
Motley Fool
Sat, 12/18/21 - 10:46 pm
Moderna Therapeutics
Pfizer
AstraZeneca
COVID-19
vaccines
boosters
Pfizer plans to study a third shot for its Covid-19 vaccine in the youngest kids, pushing back its timeline farther
Endpoints
Fri, 12/17/21 - 11:04 am
Pfizer
COVID-19
vaccines
pediatric
clinical trials

Pages